2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

Cites (1,326)

Items 1,201–1,326 of 1,326

1. High-Risk Patients with Differentiated Thyroid Cancer T4 Primary Tumors Achieve Remnant Ablation Equally Well Using rhTSH or Thyroid Hormone Withdrawal
   Peter Bartenstein, Elisa Caballero Calabuig, CARLO LUDOVICO MAINI et al. · 2013 · Thyroid
2. Clinical Relevance of Thyroglobulin Doubling Time in the Management of Patients with Differentiated Thyroid Cancer
   Furio Pacini, Mona M. Sabra, Robert Michael Tuttle · 2011 · Thyroid
3. Concordance between thyroglobulin antibody assays
   Kevin Taylor, Damon A. Parkington, Sonia Bradbury, Helen Simpson, Sarah Jefferies, David John Halsall · 2011 · Annals of Clinical Biochemistry International Journal of Laboratory Medicine
4. Cytologic Characteristics and β-Catenin Immunocytochemistry on Smear Slide of Cribriform-Morular Variant of Papillary Thyroid Carcinoma
   Ja Seung Koo, Woo‐Hee Jung, Soon Won Hong · 2010 · Acta Cytologica
5. Does radioiodine therapy have disadvantageous effects in non‐iodine accumulating differentiated thyroid carcinoma?
   Jeroen Schaap, C. F. A. Eustatia‐Rutten, Marcel P. M. Stokkel, Thera P. Links, Michaëla Diamant, Edo A. van der Velde, Johannes Anthonius Romijn, Johannes W. A. Smit · 2002 · Clinical Endocrinology
6. Simplifying the TNM System for Clinical Use in Differentiated Thyroid Cancer
   Adedayo A. Onitilo, Jessica Marie Engel, Catharina Ihre Lundgren, Per N Hall, Lukman Thalib, Suhail A.R. Doi · 2009 · Journal of Clinical Oncology
7. Surgery and radioablation therapy combined: introducing a 1-week-condensed procedure bonding total thyroidectomy and radioablation therapy with recombinant human TSH
   Nikos Emmanouilidis, Jörg Andreas Müller, Mark D. Jäger, Stephan Kaaden, Fabian Helfritz, Zeynep Esra Güner, Holger Kespohl, Wolfgang Knitsch, Wolfram H. Knapp, Jurgen L. Klempnauer et al. · 2009 · European Journal of Endocrinology
8. Long-Term Consequence of Elevated Thyroglobulin in Differentiated Thyroid Cancer
   Ji Hye Yim, Eui Young Kim, Won Bae Kim et al. · 2012 · Thyroid
9. Low thyroglobulin concentrations after thyroidectomy increase the prognostic value of undetectable thyroglobulin levels on levo-thyroxine suppressive treatment in low-risk differentiated thyroid cancer
   Arnoldo Piccardo, Federico Arecco, Silvia Daniela Morbelli, P. Bianchi, F. Barbera, Monica Finessi, Stefania Corvisieri, Emanuela Pestarino, Luca Foppiani, G. Villavecchia et al. · 2009 · Journal of Endocrinological Investigation
10. How to Manage Thyroid Nodules With Two Consecutive Non‐Diagnostic Results on Ultrasonography‐Guided Fine‐Needle Aspiration
    Hee Jung Moon, Jin Young Kwak, Yoon Seong Choi · 2012 · World Journal of Surgery
11. Locally advanced thyroid cancer: therapeutic options.
    Nicola Avenia, Mark Ragusa, Massimo Monacelli, Filippo Calzolari, Niccolò Daddi, Luciana Di Carlo, Antonia Semeraro, Francesco Puma · 2004 · PubMed
12. Epidemiologie, Pathophysiologie, leitliniengerechte Diagnostik und Therapie des Schilddrüsenknotens
    Ralf Paschke, Kurt Werner Schmid, Roland Gärtner, Klaus Mann, Henning Dralle, Christian Reiners · 2010 · Medizinische Klinik - Intensivmedizin und Notfallmedizin
13. BRAF : A Tool in the Decision to Perform Elective Neck Dissection?
    Simone Elisa Dutenhefner, Suemi Marui, André Bandiera de Oliveira Santos · 2012 · Thyroid
14. Clinical and Professional Ethics Guidelines for the Practice of Thyroidology
    M. Sara Rosenthal, Peter Angelos, David S. Cooper, C. Fassler, Stuart G. Finder, Marguerite T. Hays, Beatriz E. Tendler · 2013 · Thyroid
15. Comparison of the influence of thyroglobulin antibodies on serum thyroglobulin values from two different immunoassays in post surgical differentiated thyroid carcinoma patients
    Marijanа Stanojević Pirković, Svetlana B. Savin, Dubravka S. Cvejic, Aleksandar Djukić, Marija Jeremić, Snežana Živančević-Simonović · 2009 · Journal of Clinical Laboratory Analysis
16. Radio‐Guided Excision of Metastatic Lymph Nodes in Thyroid Carcinoma: A Safe Technique for Previously Operated Neck Compartments
    Yeşim Erbil, Serkan Sarı, Orhan Ağcaoğlu, Feyzullah Ersöz, Adem Bayraktar, Artür Salmaslıoğlu, Osman Gözkün, İşık Adalet, Selçuk Özarmağan · 2010 · World Journal of Surgery
17. Management of Recurrent/Persistent Papillary Thyroid Carcinoma: Efficacy of the Surgical Option
    Kathryn G. Schuff · 2011 · The Journal of Clinical Endocrinology & Metabolism
18. The success rate of I-131 ablation in differentiated thyroid cancer: comparison of uptake-related and fixed-dose strategies
    Robbert B. T. Verkooijen, Frederik A. Verburg, Johannes W. van Isselt · 2008 · European Journal of Endocrinology
19. Incidence and implications of negative serum thyroglobulin but positive I‐131 whole‐body scans in patients with well‐differentiated thyroid cancer prepared with rhTSH or thyroid hormone withdrawal
    Martin H. Cherk, Peter Francis, Duncan J. Topliss, Michael Bailey, Victor Kalff · 2011 · Clinical Endocrinology
20. Long-term results of surgery for papillary thyroid carcinoma with local recurrence
    Hiroki Uchida, Tsuneo Imai, Toyone Kikumori · 2012 · Surgery Today
21. Kinetic Study of Immunoreactive Human Thyroglobulin
    Motomori Izumi, ICHIRO KUBO, Michiko Taura, Shunichi Yamashita, Isao Morimoto, Shigeru Ohtakara, Sumiaki Okamoto, Lindy F. Kumagai, Shigenobu Nagataki · 1986 · The Journal of Clinical Endocrinology & Metabolism
22. Real‐Time Quantitative PCR Measurement of Thyroglobulin mRNA in Peripheral Blood of Thyroid Cancer Patients and Healthy Subjects
    Diane Li, Asif Butt, SUE CLARKE, R. Swaminathan · 2004 · Annals of the New York Academy of Sciences
23. Frequency and clinical importance of anti-Tg auto-antibodies (ATG).
    Allah Rakha Adil, Rafaqat A Jafri, Amin Waqar, Siraj A Abbasi, Matiul-Haq, A H Asghar, Asif Jilani, Irum Naz · 2003 · PubMed
24. Sonographically‐Directed Neck Dissection for Recurrent Thyroid Carcinoma
    Lisa K. Lee, David L. Steward · 2008 · The Laryngoscope
25. Influence of 131I diagnostic dose on subsequent ablation in patients with differentiated thyroid carcinoma: discrepancy between the presence of visually apparent stunning and the impairment of successful ablation
    Ya-Hui Hu, Pei‐Wen Wang, Shan‐Tair Wang · 2004 · Nuclear Medicine Communications
26. Impact of Pregnancy on Prevalence of Goitre and Nodular Thyroid Disease in Women Living in a Region of Borderline Sufficient Iodine Supply
    Steven Karger, S. Schötz, Michael Stümvoll · 2009 · Hormone and Metabolic Research
27. Level VI Lymph Node Dissection Does Not Decrease Radioiodine Uptake in Patients Undergoing Radioiodine Ablation for Differentiated Thyroid Cancer
    Don C. Yoo, Saad Ajmal, Shilpa Gowda · 2012 · World Journal of Surgery
28. Risikostratifizierung von Patienten mit lokal aggressiven differenzierten Schilddrüsenkrebs – Ergebnisse der MSDS-Studie
    B. Riemann, J. Kramer, K. W. Schmid · 2010 · Nuklearmedizin - NuclearMedicine
29. Considerations for Personalized Surgery in Patients with Papillary Thyroid Cancer
    Ralph Patrick Tufano, Emad H. Kandil · 2010 · Thyroid
30. Side Effects of 131I for Ablation and Treatment of Well-Differentiated Thyroid Carcinoma
    Douglas Van Nostrand, John E. Freitas · 2006 · Humana Press eBooks
31. Vertebroplasty and kyphoplasty: new equipment for malignant vertebral fractures treatment.
    Salvatore Antonio Masala, Roberto Fiori, Francesco Massari, Giovanni Simonetti · 2003 · PubMed
32. Pituitary Metastases from Follicular Thyroid Carcinoma
    Flavia Prodam, Loredana Pagano, Sara Belcastro et al. · 2010 · Thyroid
33. No Adverse Affect in Clinical Outcome Using Low Preablation Diagnostic 131I Activity in Differentiated Thyroid Cancer: Refuting Thyroid-Stunning Effect
    Beng Khiong Yap, Brian Murby · 2014 · The Journal of Clinical Endocrinology & Metabolism
34. Comparative activity of cisplatin, ifosfamide, doxorubicin, carboplatin, and etoposide in heterotransplanted hepatoblastoma
    Jörg Fuchs, Marc Wenderoth, Dietrich von Schweinitz, Johann Haindl, Ivo Leuschner · 1998 · Cancer
35. Information for Decision Making by Patients With Early-Stage Prostate Cancer
    Deb Feldman‐Stewart, Carlo Capirci, Sarah Brennenstuhl, Christine Tong, Ufuk Abacıoğlu, Marzena Gawkowska‐Suwińska, Francis C. J. M. van Gils, Alicja Heyda, Şefik İğdem, Víctor Macías et al. · 2011 · Medical Decision Making
36. Differential effects between cyclooxygenase‐2 inhibitors and siRNA on vascular endothelial growth factor production in head and neck squamous cell carcinoma cell lines
    Seokwoo Park, Hyo‐Sun Kim, Jeong Hun Hah · 2010 · Head & Neck
37. Early detection of isolated left ventricular diastolic dysfunction in high-risk differentiated thyroid carcinoma patients on TSH-suppressive therapy
    Véronique Taillard, Mathieu Sardinoux, Carole Oudot, Pierre Fesler, Caroline Rugale, I. Raingeard, Éric Renard, Jean Ribstein, Guilhem du Cailar · 2011 · Clinical Endocrinology
38. Two Weeks of a Low-Iodine Diet Are Equivalent to 3 Weeks for Lowering Urinary Iodine and Increasing Thyroid Radioactive Iodine Uptake
    Eveline Predebon Morsch, Roberta Vanacor, Tânia Weber Furlanetto · 2010 · Thyroid
39. Thyroid lobe ablation with iodine-131 in patients with differentiated thyroid carcinoma
    Luca Giovanella, Arnoldo Piccardo, Gaetano Paone · 2013 · Nuclear Medicine Communications
40. A case of stunning of lung and bone metastases of papillary thyroid cancer after a therapeutic dose (3.7 GBq) of131I and review of the literature: implications for sequential treatments
    Aubène Léger, M Pellan, F Dagousset, Alain Chevalier, Isabelle Keller, Jérôme Clerc · 2005 · British Journal of Radiology
41. Changes in risk factors and Tumor Node Metastasis stage of sporadic medullary thyroid carcinoma over 41 years, before and after the routine measurements of serum calcitonin
    Helen Karga, Irene Giagourta, Garyphallia Papaioannou · 2010 · Metabolism
42. A randomized clinical trial comparing 50mCi and 100mCi of iodine-131 for ablation of differentiated thyroid cancers.
    Maseeh uz Zaman, Rafia Toor, Shahid Kamal, Minhaj Maqbool, Salman Habib, Khalid Niaz · 2006 · PubMed
43. Minimal-invasives follikuläres Schilddrüsenkarzinom
    Martin Hermann, K. Tonninger, Friedrich Kober · 2010 · Der Chirurg
44. Unilateral Radioiodine Breast Uptake
    SIEMA M. B. BAKHEET, John Powe, Muhammad Maher Hammami · 1998 · Clinical Nuclear Medicine
45. Long-term outcome of lobar ablation versus completion thyroidectomy in differentiated thyroid cancer
    Amburanjan Santra, Susan Bal, Sagar Mahargan, Chandrasekhar Bal · 2010 · Nuclear Medicine Communications
46. What is the appropriate extent of lateral neck dissection in the treatment of metastatic well‐differentiated thyroid carcinoma?
    Christian P. Hasney, Ronald G. Amedee · 2010 · The Laryngoscope
47. Papillary Thyroid Carcinoma with Brain Metastases: An Unusual 10-Year-Survival Case
    Elizabete Rosária de Miranda, Eduardo Lanza Padrao, Barbara Campolina Carvalho Silva · 2010 · Thyroid
48. Evolution of benign thyroid nodules under levothyroxine non-suppressive therapy
    Alessandro Puzziello, Mario Carrano, Elisabetta Angrisani · 2014 · Journal of Endocrinological Investigation
49. Value of Repeat Stimulated Thyroglobulin Testing in Patients with Differentiated Thyroid Carcinoma Considered to Be Free of Disease in the First Year After Ablation
    Pedro Weslley Rosário, Mariana de Souza Furtado, Augusto Flávio Campos Mineiro Filho · 2011 · Thyroid
50. Utility of BRAF mutation detection in fine‐needle aspiration biopsy samples read as “suspicious for papillary thyroid carcinoma”
    Sebastian M. Jara, Ramneesh Bhatnagar, Hui Guan · 2014 · Head & Neck
51. A Systematic Review of Randomized Controlled Trials for Management of Persistent Post-Treatment Fatigue in Thyroid Cancer Survivors
    Joshua To, Alyse S. Goldberg, Jennifer Michelle Jones, Junhui Zhang, Julia M. LOWE, Shereen Ezzat, Jeremy D. Gilbert, Afshan Zahedi, Phillip Segal, Anna M. Sawka · 2014 · Thyroid
52. Comparison of thyroglobulin antibody interference in first- and second-generation thyroglobulin immunoassays
    Luca Giovanella, Luca Ceriani · 2011 · Clinical Chemistry and Laboratory Medicine (CCLM)
53. Life-Threatening Hyponatremia Following a Low-Iodine Diet: A Case Report and Review of all Reported Cases
    Omar Mansour Al Nozha, Line Vautour, Jacques How · 2011 · Endocrine Practice
54. Cervicomediastinal Magnetic Resonance Imaging in Persistent or Recurrent Papillary Thyroid Carcinoma: Clinical Use and Limits
    Marie‐Elisabeth Toubert, Françoise Cyna-Gorse, Anne–Marie Zagdanski · 1999 · Thyroid
55. Radioiodine therapy for differentiated thyroid carcinoma with thyroglobulin positive and radioactive iodine negative metastases
    Chao Ma, Anren Kuang, Jiawei Xie · 2009 · Cochrane Database of Systematic Reviews
56. Encapsulated follicular variant of papillary thyroid carcinoma.
    Hunt Jl, Sanja Đačić, E L Barnes, Bures Jc · 2002 · PubMed
57. Verfahrensanweisung zur Radioiodtherapie und 131I-Ganzkörperszintigraphie bei differenzierten Schilddrüsenkarzinomen im Kindes- und Jugendalter
    Christiane Franzius, Markus Dietlein, Martin Biermann · 2007 · Nuklearmedizin - NuclearMedicine
58. Kalzitoninbestimmung zur Frühdiagnose des medullären Schilddrüsenkarzinoms
    Wölfram Karges · 2010 · Der Chirurg
59. Usefulness of 124I PET/CT imaging to predict absorbed doses in patients affected by metastatic thyroid cancer and treated with 131I.
    Cinzia Pettinato, Fabio Monari, Cristina Nanni · 2012 · PubMed
60. Neural Monitored Revision Thyroid Cancer Surgery: Surgical Safety and Thyroglobulin Response
    Eimear Phelan, Dipti Kamani, Jennifer Joan Shin · 2013 · Otolaryngology
61. The role of total thyroidectomy in the management of differentiated thyroid cancer.
    Stephenson Bm, Wheeler Mh, Clark Oh · 1994 · PubMed
62. A Pragmatic Protocol for I-131 rhTSH-Stimulated Ablation Therapy in Patients With Renal Failure
    A. A. Driedger, Sarah Quirk, Tom J. McDonald, S Ledger, D Gray, W Wall, John J. Yoo · 2006 · Clinical Nuclear Medicine
63. Electronic Synoptic Operative Reporting for Thyroid Surgery using an Electronic Data Management System: Potential for Prospective Multicenter Data Collection
    Narayanan Gopalakrishna Iyer, Iain James Nixon, Frank L. Palmer · 2010 · Annals of Surgical Oncology
64. Long-Term Follow-Up of At Least Five Years After Recombinant Human Thyrotropin Compared to Levothyroxine Withdrawal for Thyroid Remnant Ablation with Radioactive Iodine
    Pedro Weslley Rosário, Augusto Flávio Campos Mineiro Filho, Rafaela Xavier Lacerda · 2012 · Thyroid
65. Revised guidelines for the management of thyroid cancer
    Kristien Boelaert · 2010 · Nature Reviews Endocrinology
66. The Effectiveness of Recombinant Human Thyroid-Stimulating Hormone versus Thyroid Hormone Withdrawal Prior to Radioiodine Remnant Ablation in Thyroid Cancer: A Meta-Analysis of Randomized Controlled Trials
    Kyoungjune Pak, Gi Jeong Cheon, Keon Wook Kang · 2014 · Journal of Korean Medical Science
67. The prevalence and clinical significance of 18F–2‐fluoro‐2‐deoxy‐D‐glucose (FDG) uptake in the thyroid gland on PET or PET‐CT in patients with lymphoma
    Michael F. Lin, Christine Y. Wong, Peter Lin · 2010 · Hematological Oncology
68. Role of Tc-99m Pertechnetate for Remnant Scintigraphy Post-Thyroidectomy
    Sherman S. H. Kueh, PAUL J. ROACH, Geoffrey Paul Schembri · 2010 · Clinical Nuclear Medicine
69. Radioiodine Thyroid Remnant Ablation after Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal in Patients with High-Risk Differentiated Thyroid Cancer
    Fabián Pitoia, Robert J. Marlowe, Erika Abelleira · 2012 · Journal of Thyroid Research
70. Correlation of Thyroglobulin Concentrations Measured by Radioimmunoassay and Immunoradiometric Assay and the Influence of Thyroglobulin Antibody
    Marijanа Stanojević Pirković, Svetlana B. Savin, Dubravka S. Cvejic · 2009 · Journal of Immunoassay and Immunochemistry
71. Risk Factors of Lymph Node Metastasis in Papillary Thyroid Microcarcinoma
    Nam Seop Lee, Ja Seong Bae, So-Ryeong Jeong · 2010 · Journal of the Korean Surgical Society
72. Follicular Neoplasm/Suspicious for a Follicular Neoplasm
    Michael R. Henry, Richard M. DeMay, Katherine Berezowski · 2009 · Springer eBooks
73. Follicular Neoplasm, Hürthle Cell Type/Suspicious for a Follicular Neoplasm, Hürthle Cell Type
    William C. Faquin, Claire W. Michael, Andrew A. Renshaw · 2009 · Springer eBooks
74. Hematologic Toxicity in Patients Treated with Sunitinib for Advanced Thyroid Cancer
    Anastasios Gkountouvas, Ifigeneia Kostoglou-Athanassiou, Eirini Veniou · 2010 · Thyroid
75. Intraoperative Pathologic Examination in the Era of Molecular Testing for Differentiated Thyroid Cancer
    Kelly L. McCoy, Sally E. Carty, Michaele J. Armstrong · 2012 · Journal of the American College of Surgeons
76. rhTSH-aided low-activity versus high-activity regimens of radioiodine in residual ablation for differentiated thyroid cancer
    Chao Ma, Limin Tang, Hongliang Fu · 2013 · Nuclear Medicine Communications
77. Detection of Metastatic Cervical Lymph Nodes in Recurrent Papillary Thyroid Carcinoma
    Dong Hoon Lee, Won Jun Kang, Hyung Suk Seo, Eunhee Kim, Ji‐hoon Kim, Kyu-Ri Son, Dong Gyu Na · 2009 · Journal of Computer Assisted Tomography
78. Validation of the QTNM staging system for cancer-specific survival in patients with differentiated thyroid cancer
    Daniel Mankarios, Peter David Baade, Pip Youl, R.H. Mortimer, Adedayo A. Onitilo, Anthony William Russell, Suhail A.R. Doi · 2013 · Endocrine
79. Radioiodine therapy for patients with differentiated thyroid cancer after thyroidectomy: direct comparison and network meta-analyses.
    Yan Fang, Yudan Ding, Qing Guo · 2013 · PubMed
80. Clinical prognostic index for recurrence of papillary thyroid carcinoma including intraoperative findings
    Kwang Min Kim, Joon Beom Park, Keum Seok Bae · 2012 · Endocrine Journal
81. Visualization of Thyroglossal Duct Cyst in Differentiated Thyroid Cancer Patient
    Dong Li, Zhaowei Meng, Guizhi Zhang · 2010 · Clinical Nuclear Medicine
82. Diagnostic 131I whole-body scintigraphy 1 year after thyroablative therapy in patients with differentiated thyroid cancer: correlation of results to the individual risk profile and long-term follow-up
    Frank Berger, Ulla Friedrich, P. Knesewitsch · 2010 · European Journal of Nuclear Medicine and Molecular Imaging
83. Endogenous Serum TSH Levels and Metastatic Survey Scans in Thyroid Cancer Patients Using Triiodothyronine Withdrawal
    Neil D. Martin · 1978 · Clinical Nuclear Medicine
84. Are pre-operative vocal fold checks necessary?
    K M J Green, J. P. de Carpentier · 1999 · The Journal of Laryngology & Otology
85. On the effectiveness of recombinant human TSH as a stimulating agent for 131I treatment of metastatic differentiated thyroid cancer
    Paolo Zanotti‐Fregonara, Elif Hindié · 2010 · European Journal of Nuclear Medicine and Molecular Imaging
86. Thyroid Fine Needle Aspiration Biopsies in Children: Study of Cytological-Histological Correlation and Immunostaining with Thyroid Peroxidase Monoclonal Antibodies
    Victoria Hoperia, О. С. Ларін, Kirk Ernest Jensen · 2010 · International Journal of Pediatric Endocrinology
87. Managing Patients with a Preoperative Diagnosis of AJCC/UICC Stage I (T1N0M0) Papillary Thyroid Carcinoma: East Versus West, Whose Policy is Best?
    IAN D. HAY · 2010 · World Journal of Surgery
88. Ultrasonographic screening for occult thyroid cancer
    Anthony Po Wing Yuen, Ambrose Chung‐Wai Ho, Birgitta Y. H. Wong · 2010 · Head & Neck
89. Suspicious for Malignancy
    Helen H. Wang, Armando Carlos Filie, Douglas P. Clark · 2009 · Springer eBooks
90. Management of Well-Differentiated Thyroid Cancer in 2010: Perspectives of a Head and Neck Surgical Oncologist
    Mark L. Urken · 2010 · Endocrine Practice
91. Correlation of Findings from Iodine 123 Scan and Ultrasonography in the Recommendation for Thyroid Fine-Needle Aspiration Biopsy
    Jill E. Langer, Rajan Agarwal, Hongming Zhuang · 2011 · Endocrine Practice
92. Enlarged Benign-Appearing Cervical Lymph Nodes by Ultrasonography Are Associated with Increased Likelihood of Cancer Somewhere Within the Thyroid in Patients Undergoing Thyroid Nodule Evaluation
    Kathleen E. Hands, Antonio Cervera, Larry J. Fowler · 2010 · Thyroid
93. Radioiodine Accumulation in a Large Adnexal Cystadenofibroma
    Ömer Türker, İsmail Doğan, Kamil Kumanlıoğlu · 2010 · Thyroid
94. The Differentiation of Benign and Malignant Thyroid Nodules
    Carrie Cunningham Lubitz, Thomas J. Fahey · 2005 · Advances in Surgery
95. Thyroid pathology in four patients with Cowden’s disease
    Christine T. Hemmings · 2003 · Pathology
96. [Surgical treatment of advanced thyroid carcinoma with aero-digestive invasion].
    Jun-heng Ge, Ruili Zhao, Junlan Hu, Wei-an Zhou · 2004 · PubMed
97. Nondiagnostic/Unsatisfactory
    Barbara A. Crothers, Michael R. Henry, Pınar Fırat · 2009 · Springer eBooks
98. Burkitt-Like Lymphoma Infiltrating a Hyperfunctioning Thyroid Adenoma and Presenting as a Hot Nodule
    Antonella Camera, Flavia Magri, R. Fonte · 2010 · Thyroid
99. Large Discrepancy in the Results of Sensitive Measurements of Thyroglobulin Antibodies in the Follow-Up on Thyroid Cancer: A Diagnostic Dilemma
    Birte Nygaard, Jens Bentzen, Peter Laurberg, Susanne Møller Pedersen, Lars Bastholt, Aase Handberg, Carsten Rytter, Christian Godballe, Jens Oscar Faber · 2012 · European Thyroid Journal
100. Long-Term Results after Treatment of Very Low-, Low-, and High-Risk Thyroid Cancers in a Combined Setting of Thyroidectomy and Radio Ablation Therapy in Euthyroidism
     Nikos Emmanouilidis, Harald Schrem, Michael Winkler, Jurgen L. Klempnauer, Georg F. W. Scheumann · 2013 · International Journal of Endocrinology
101. Fine-Needle Biopsy Should Be Performed in Solid Hypoechoic Thyroid Nodules Greater Than One Centimeter Even in the Absence of Suspicious Ultrasonographic Characteristics
     Pedro Weslley Rosário, Daniela Santos Salles, Saulo Purisch · 2010 · Thyroid
102. Resveratrol, Thyroid Cancer, and Iodide: Drink Up?
     John C. Morris · 2010 · Thyroid
103. Protein Kinase Inhibitor Therapy in Advanced Thyroid Cancer: Ethical Challenges and Potential Solutions
     Keith Christopher Bible, Kenneth B. Ain, M. Sara Rosenthal · 2014 · International Journal of Endocrine Oncology
104. Do Thyroid Cancer Patients with Basal Undetectable Tg Measured by Current Immunoassays Require rhTSH Testing?
     Gonzalo Díaz-Soto, Manel Puig‐Domingo, Isabel Martínez‐Pino, María Jesús Martínez de Osaba, Mireia Mora, Francisca Rivera‐Fillat, Irene Halperín · 2011 · Experimental and Clinical Endocrinology & Diabetes
105. Oncofetal Fibronectin mRNA Is Highly Abundant in the Blood of Patients with Papillary Thyroid Carcinoma and Correlates with High-Serum Thyroid-Stimulating Hormone Levels
     Michael Wehmeier, Thorsten Petrich, Korbinian Brand · 2010 · Thyroid
106. Response of thyroglobulin to radioiodine therapy in thyroglobulin-elevated negative iodine scintigraphy (TENIS) syndrome.
     Partha Sinha, Gary R. Conrad, Hollie C West · 2011 · PubMed
107. First treatment activity and outcome of radioiodine therapy in thyroid cancer patients with metastases in lymph nodes: mathematical correlation and clinical implications.
     Orhan Kozak, L V Muzichenko, Alexander M Trembach, Natalia U Voit, V V Turicina · 2006 · PubMed
108. Thyroid Surgery and Surgeons: The Common Interest
     John Hosei Yim, Sally E. Carty · 2010 · Thyroid
109. Evolution in the surgical management of well‐differentiated thyroid cancer or not: To dissect or not dissect the central lymph node compartment
     Martha A. Zeiger · 2009 · Journal of Surgical Oncology
110. Medullary Thyroid Carcinoma
     Robert F. Gagel · 2005 · Springer eBooks
111. Tumortyp- und tumorstadienorientiertes chirurgisches Konzept bei Karzinomen der Schilddrüse
     Henning Dralle, Kerstin Lorenz, Andreas Machens · 2010 · Der Onkologe
112. Surgery of Well-Differentiated Thyroid Carcinoma: The Pendulum Swings Back in the Central Neck
     Gregory William Randolph, Elizabeth N. Pearce · 2010 · Endocrine Practice
113. Guidelines for Guidelines: Content, Accountability, Peer Review, and Intellectual Ownership
     Charles H. Emerson · 2009 · Thyroid
114. Screening of Thyroid Cancer and Management of Thyroid Incidentaloma
     Jung Jin Cho · 2010 · Korean Journal of Family Medicine
115. Schilddrüsenkarzinom – Klinik und Diagnostik
     Wölfram Karges, Georg E. Brabant · 2010 · Der Onkologe
116. How reliable is secondary risk stratification with stimulated thyroglobulin in patients with differentiated thyroid carcinoma?
     Johanna Berta Lemb, Michael Hüfner, Birgit Meller · 2013 · Nuklearmedizin - NuclearMedicine
117. Nuklearmedizinische Therapie und Nachsorge des differenzierten Schilddrüsenkarzinoms: Status quo
     Markus Dietlein, Markus Luster, Christoph Reiners · 2010 · Der Onkologe
118. Die Rolle der externen Strahlentherapie bei der Behandlung des Schilddrüsenkarzinoms
     Dirk Vordermark, Tanja Pelz, Frank Sieker · 2010 · Der Onkologe
119. Is Screening Appropriate for Occult Cervical Lymph Node Metastases in Patients with Well-Differentiated Thyroid Cancer?
     Keith Stuart Heller · 2010 · Thyroid
120. Hypothyroidism in Pregnancy: Do Guidelines Alter Practice?
     Elizabeth N. Pearce, Alex Stagnaro‐Green · 2010 · Thyroid
121. Central Lymph Node Metastasis as a Predictor of Lateral Node Involvement in Papillary Thyroid Carcinoma: Reply to Letter
     Guizhou Xiao · 2010 · World Journal of Surgery
122. Simultaneous Metastatic Papillary Thyroid Carcinoma and Carcinoid of the Small Intestine in the Cervical Lymph Node Group
     Konstantinos D. Markou, John K. Goudakos, Stefanos Triaridis · 2010 · Thyroid
123. Response to Pitoia and Ward
     David S. Cooper · 2010 · Thyroid
124. Central Lymph Node Metastasis: Is It a Reliable Indicator of Node Involvement in Papillary Thyroid Carcinoma? Letter to the Editor
     P. V. Pradeep, Sheela Kuldeep · 2010 · World Journal of Surgery
125. Untitled work
     Caraceni · 1998 · 10.1002/(sici)1097-0142(19980801)83:3
126. 5-Aminolevulinic acid-based photodynamic therapy
     1997